Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes

Oct. 22, 2012

NEPTUNE I and II data on tamsulosin/solifenacin presented

Oct. 22, 2012

MM-433593 human pharmacokinetic data presented

Oct. 22, 2012

Trius Therapeutics synthesizes novel dual-target antibacterial agents

Oct. 22, 2012

Researchers describe activity of TAC-302

Oct. 19, 2012

Studies support the use of tofogliflozin in patients with renal impairment

Oct. 19, 2012

Novel deuterated analogues of mibefradil show reduced propensity for CYP3A4-mediated interactions

Oct. 19, 2012

Novel antidiabetic drug Subetta evaluated in animal model

Oct. 19, 2012

Amgen presents novel TRPM8 channel antagonist

Oct. 19, 2012

Preclinical pharmacokinetic properties disclosed for G-773

Oct. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...